Answers are grounded in this paper and cite their sources.
Sciatic nerve crush injury is a disabling peripheral compression neuropathy characterized by chronic pain, tissue adhesion, impaired nerve function, and progressive muscle atrophy. Current treatments often lack site specificity and may cause secondary tissue injury. Mild pulsed magnetic field (PMF) stimulation emerges as a promising noninvasive approach for peripheral nerve disorders, but its efficacy in deep‐seated lesions is limited by field attenuation. Herein, we develop a magnetic sciatic nerve stimulation (mSNS) strategy based on a thermo‐responsive magnetic injectable hydrogel (MIH), in which iron oxide nanoparticles (IONPs) are incorporated into a chitosan/β‐glycerophosphate matrix to enable localized magnetic stimulation. In silico electromagnetic simulations characterize the magnetic field intensity and frequency tunability of the mSNS platform. Therapeutic efficacy is evaluated in a rat model of SNE using local MIH administration combined with moderate‐intensity rotational PMF stimulation. Electromagnetic simulations demonstrate stable and frequency‐tunable rotational magnetic fields with a peak intensity of 90 mT. In vivo, localized MIH administration enhances magnetic field exposure at the entrapment site, significantly improving nerve conduction, motor and sensory function, and mechanical pain thresholds, while reducing gastrocnemius muscle atrophy. mSNS treatment also promotes Schwann cell proliferation and upregulates markers associated with axonal growth and remyelination, including GAP‐43, β‐tubulin, TRKB, NF‐200, and MBP, accompanied by immunofluorescence evidence suggestive of myelinated nerve architecture preservation. Moreover, mSNS exhibits favorable systemic biocompatibility without detectable organ toxicity or hepatic or renal dysfunction. Overall, MIH‐mediated targeted magnetic stimulation promotes sciatic nerve repair and functional recovery, providing a promising therapeutic strategy for peripheral nerve compression neuropathies.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: